Synabs

Singular monoclonal antibodies

SYnAbs' vision is to fill the gap on the marketplace for innovative mAbs against poor immunogenic compounds and complex antigens. Targeting steroids, peptides, small molecules, toxins, lipids and polysaccharides (on fungi and bacteria), SYnAbs has developed a strong expertise in immunology to break immunotolerance in rat and guinea pig species to generate unique monoclonal antibodies of extreme specificity and higher affinity.

 

Product Range:

- SYnAbs Singular Antibodies
- Primary monoclonal antibodies
- Secondary monoclonal antibodies
- Custom monoclonal antibody development
- Immunoassays

https://www.synabs.be/

Show Product